Prevalence of Markers of Certain Blood-Borne Viral Infections in Pregnant Women and Their Partners in the Republic of Guinea

The aim of the work was to estimate the prevalence of HIV, HBV and HCV markers among pregnant women and their male partners in the Republic of Guinea.

Materials and methods. The material of the study was blood plasma samples from 140 pregnant women living in Kindia prefecture and N’Zerekore prefecture, as well as 60 male partners who reported sexual contact with HIV-infected persons. The samples were examined for the presence of serological (HBsAg, HBeAg, antibodies anti-HBs IgG, anti-HBcore IgG, anti-HBe IgG, anti-HCV IgG, Ag/Ab-HIV) and molecular (HBV DNA, HCV RNA, HIV RNA) markers.

Results and discussion. The age of the examined pregnant women ranged from 13 to 55 years and was on average (26.29±9.67) years. The age of men varied from 15 to 60 years, on average – (29.05±11.99) years. When assessing the prevalence of serological markers, antibodies to HCV were detected in 2.14 % cases in women and in 3.33 % cases in men. Antibodies to HIV were found in 6.43 % and 6.67 % women and men, respectively. Serological markers associated with HBV were detected in 80.71 % (HBsAg – 13.57 %) of women and 81.67 % (15 %) of men. In the pregnant women, HCV RNA was not detected, HIV RNA was revealed in 1 case, HBV DNA was identified in 26 cases (18.57 %), including 5 % HBsAg-negative hepatitis B cases. In the men group, HCV RNA and HIV RNA were detected in 3.33 % and 6.67 % cases, respectively. HBV DNA was determined in 16.67 % of men, including latent hepatitis B in one person. A significantly higher incidence of HIV in men compared to women is shown (χ2=3.907 at p<0.05). The relative risk of HIV infection in men is nine times higher than in women: RR=9.333; p=0.0291; 95 % CI: 1.065–81.815 %. Four out of five identified HIV infection cases were co-infected with HBV and/or HCV. There is an obvious need to introduce screening for HIV, HCV, HBV, including latent hepatitis B, into routine laboratory diagnostics during examination of pregnant women and their partners, followed by couples counseling and vaccination against hepatitis B virus.

1. World Health Organization. Hepatitis B. Key facts. (Cited 08 Sept 2022). [Internet]. Available from: http://www.who.int/newsroom/fact-sheets/detail/hepatitis-b.

2. World Health Organization. Hepatitis C. Key facts. (Cited 08 Sept 2022). [Internet]. Available from: https://www.who.int/newsroom/fact-sheets/detail/hepatitis-c.

3. World Health Organization. HIV. Key facts. (Cited 08 Sept 2022). [Internet]. Available from: https://cdn.who.int/media/docs/default-source/hq-hiv-hepatitis-and-stis-library/key-facts-hiv-2020.pdf?sfvrsn=582c3f6e_3.

4. Raizada A., Dwivedi S., Bhattacharya S. The hepatitis B, hepatitis C and HIV co-infection at an antiretroviral centre in Delhi. Trop. Doct. 2011; 41(3):154–6. DOI: 10.1258/td.2011.100440.

5. Degenhardt L., Charlson F., Stanaway J., Larney S., Alexander L.T., Hickman M., Cowie B., Hall W.D., Strang J., Whiteford H., Vos T. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect. Dis. 2016; 16(12):1385–98. DOI: 10.1016/S1473-3099(16)30325-5.

6. Roser М., Ritchie Н. HIV/AIDS. Published online at OurWorldInData.org. (Cited 08 Sept 2022). [Internet]. Available from: https://ourworldindata.org/hiv-aids.

7. GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022; 7(9):796–829. DOI: 10.1016/S2468-1253(22)00124-8.

8. The Polaris Observatory HCV Collaborators. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol. 2022; 7(5):396–415. DOI: 10.1016/S2468-1253(21)00472-6.

9. Nkuoh G.N., Meyer D.J., Nshom E.M. Women’s attitudes toward their partners’ involvement in antenatal care and prevention of mother-to-child transmission of HIV in Cameroon, Africa. J. Midwifery Womens Health. 2013; 58(1):83–91. DOI: 10.1111/j.1542-2011.2012.00208.x.

10. Hershow R.B., Zimba C.C., Mweemba O., Chibwe K.F., Phanga T., Dunda W., Matenga T., Mutale W., Chi B.H., Rosenberg N.E., Maman S. Perspectives on HIV partner notification, partner HIV self-testing and partner home-based HIV testing by pregnant and postpartum women in antenatal settings: a qualitative analysis in Malawi and Zambia. J. Int. AIDS Soc. 2019; 22 Suppl 3(Suppl Suppl 3):e25293. DOI: 10.1002/jia2.25293.

11. Amano A., Musa A. Male involvement in PMTCT and associated factors among men whom their wives had ANC visit 12 months prior to the study in Gondar town, North west Ethiopia, December, 2014. Pan Afr. Med. J. 2016; 24:239. DOI: 10.11604/pamj.2016.24.239.8460.

12. Drammeh B., Medley A., Dale H., De A.K., Diekman S., Yee R., Aholou T., Lasry A., Auld A., Baack B., Duffus W., Shahul E., Wong V., Grillo M., Al-Samarrai T., Ally S., Nyangulu M; MCHD2; Nyirenda R., Olivier J., Chidarikire T., Khanyile N., Kayange A.A., Rwabiyago O.E., Kategile U., Bisimba J., Weber R.A., Ncube G., Maguwu O., Pietersen I., Mali D., Dzinotyiweyi E., Nelson L., Bosco M.J., Dalsone K., Apolot M., Anangwe S., Soo L.K., Mugambi M., Mbayiha A., Mugwaneza P., Malamba S.S., Phiri A.; MCD28; Chisenga T., Boyd M., Temesgan C., Shimelis M., Weldegebreal T., Getachew M., Balachandra S., Eboi E., Shasha W., Doumatey N., Adjoua D., Meribe C., Gwamna J., Gado P., John-Dada I., Mukinda E., Lukusa L.F.K., Kalenga L., Bunga S., Achyut V., Mondi J., Loeto P., Mogomotsi G., Ledikwe J., Ramphalla P., Tlhomola M., Mirembe J.K., Nkwoh T., Eno L., Bonono L., Honwana N., Chicuecue N., Simbine A., Malimane I., Dube L., Mirira M., Mndzebele P., Frawley A., Cardo Y.M.R., Behel S. Sex differences in HIV testing – 20 PEPFAR-supported sub-Saharan African countries, 2019. MMWR Morb. Mortal. Wkly Rep. 2020; 69(48):1801–6. DOI: 10.15585/mmwr.mm6948a1.

13. Guinea Population. (Cited 18 Aug 2022). [Internet]. Available from: https://countrymeters.info/en/Guinea.

14. Chersich M.F., Gray G., Fairlie L,, Eichbaum Q., Mayhew S., Allwood B., English R., Scorgie F., Luchters S., Simpson G., Haghighi M.M., Pham M.D., Rees H. COVID-19 in Africa: care and protection for frontline healthcare workers. Global. Health. 2020; 16(1):46. DOI: 10.1186/s12992-020-00574-3.

15. Naidenova E.V., Lopatin A.A., Safronov V.A., Kolomoets E.V., Levkovskiy A.E., Silla A.L., Starshinov V.A., Shcherbakova S.A., Maleyev V.V. [Biological safety at carrying out anti-epidemic measures during the liquidation of the epidemic Ebola fever in the Republic of Guinea]. Infektsionnye Bolezni: Novosti, Mneniya, Obuchenie [Infectious Diseases: News, Opinions, Training]. 2018; 7(3):102–8. DOI: 10.24411/2305-3496-2018-13015.

16. Kolomoets E.V., Itskov Y.Yu., Naidenova E.V., Konomou V., Keita S., Lamah R. [Creation and support of operation of a hospital net to treat COVID-19 patients in Guinea]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2021; (3):66–71. DOI: 10.21055/0370-1069-2021-3-66-71.

17. Annuaire Statistique 2021. (Cited 20 Aug 2022). [Internet]. Available from: http://www.stat-guinee.org/images/Documents/Publications/INS/annuelles/annuaire/Annuaire_Statistique_2021_vf.pdf.

18. Leno N.N., Delamou A., Koita Y., Diallo T.S., Kaba A., Delvaux T., Van Damme W., Laga M. Ebola virus disease outbreak in Guinea: what effects on prevention of mother-to-child transmission of HIV services? Reprod. Health. 2018; 15(1):60. DOI: 10.1186/s12978-018-0502-y.

19. Camara B.S., Delamou A., Diro E., Béavogui A.H., El Ayadi A.M., Sidibé S., Grovogui F.M., Takarinda K.C., Bouedouno P., Sandouno S.D., Okumura J., Baldé M.D., Van Griensven J., Zachariah R. Effect of the 2014/2015 Ebola outbreak on reproductive health services in a rural district of Guinea: an ecological study. Trans. R. Soc. Trop. Med. Hyg. 2017; 111(1):22–9. DOI: 10.1093/trstmh/trx009.

20. Balde T., Boumbaly S., Serikova E.N., Valutite D.E., Shchemelev A.N., Ostankova Yu.V., Zueva E.B., Semenov A.V. [Comparative Analysis of the Vertical Risk of Transmission of Some Blood-Borne Infections in the Republic of Guinea]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2021; (1):87–94. DOI: 10.21055/0370-1069-2021-1-87-94.

21. Ostankova Yu.V., Serikova E.N., Semenov A.V., Totolian Areg A. [Method for detecting hepatitis B virus DNA in biological material at low viral load based on nested PCR with realtime detection of three viral targets]. Klinicheskaya Laboratornaya Diagnostika [Clinical Laboratory Diagnostics]. 2022; 67(9):530–7. DOI: 10.51620/0869-2084-2022-67-9-530-537.

22. Mbange A.E., Kaba D., Diouara A.A.M., Diop-Ndiaye H., Ngom-Ngueye N.F., Dieng A., Lo S., Toure K.N., Fall M., Mbacham W.F., Diallo M.S., Cisse M., Mboup S., Kane C.T. Surveillance of transmitted HIV-1 antiretroviral drug resistance in the context of decentralized HIV care in Senegal and the Ebola outbreak in Guinea. BMC Res. Notes. 2018; 11(1):723. DOI: 10.1186/s13104-018-3804-9.

23. Ingasia L.A.O., Kostaki E.G., Paraskevis D., Kramvis A. Global and regional dispersal patterns of hepatitis B virus genotype E from and in Africa: A full-genome molecular analysis. PLoS One. 2020; 15(10):e0240375. DOI: 10.1371/journal.pone.0240375.

24. Clifford G.M., Waterboer T., Dondog B., Qiao Y.L., Kordzaia D., Hammouda D., Keita N., Khodakarami N., Raza S.A., Sherpa A.T., Zatonski W., Pawlita M., Plummer M., Franceschi S. Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa. Infect. Agent. Cancer. 2017; 12:9. DOI: 10.1186/s13027-017-0121-1.

25. Naughton B., Bulterys M.A., Mugisha J., Mujugira A., Boyer J., Celum C., Weiner B., Sharma M. ‘If there is joy… I think it can work well’: a qualitative study investigating relationship factors impacting HIV self-testing acceptability among pregnant women and male partners in Uganda. BMJ Open. 2023; 13(2):e067172. DOI: 10.1136/bmjopen-2022-067172.

26. UNAIDS data 2020. UNAIDS. Jul 2020. (Cited 18 Aug 2022). [Internet]. Available from: https://www.unaids.org/en/resources/documents/2020/unaids-data.

27. Bekolo C.E., Soumah M.M., Tiemtore O.W., Diallo A., Yuma J.D., Di Stefano L., Metcalf C., Cisse M. Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea. BMC Cancer. 2017; 17(1):806. DOI: 10.1186/s12885-017-3771-x.

28. Shchemelev A.N., Boumbaly S., Ostankova Y.V., Zueva E.B., Semenov A.V., Totolian A.A. Prevalence of drug resistant HIV-1 forms in patients without any history of antiretroviral therapy in the Republic of Guinea. J. Med. Virol. 2022; 95(1):e28184. DOI: 10.1002/jmv.28184.

29. Boumbaly S., Serikova E.N., Semenov A.V., Ostankova Yu.V., Valutite D.E., Shchemelev A.N., Zueva E.B., Balde T.A.L., Baimova R.R., Totolian A.A. [Significance of laboratory diagnosis of parenteral viral hepatitis in the Republic of Guinea]. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2021; 98(4):440–9. DOI: 10.36233/0372-9311-116.

30. Sanjuán R. The social life of viruses. Annu. Rev. Virol. 2021; 8(1):183–99. DOI: 10.1146/annurev-virology-091919-071712.

31. Huy B.V., Vernavong K., Kính N.V. HBV and HCV coinfection among HIV/AIDS patients in the National hospital of tropical diseases, Vietnam. AIDS Res. Treat. 2014; 2014:581021. DOI: 10.1155/2014/581021.